Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M73,538Revenue $M6,932Net Margin (%)25.6Z-Score15.5
Enterprise Value $M72,171EPS $7.8Operating Margin %36.0F-Score8
P/E(ttm))34.4Cash Flow Per Share $7.4Pre-tax Margin (%)35.9Higher ROA y-yY
Price/Book7.710-y EBITDA Growth Rate %25.7Quick Ratio1.7Cash flow > EarningsY
Price/Sales8.95-y EBITDA Growth Rate %20.1Current Ratio2.1Lower Leverage y-yY
Price/Cash Flow20.5y-y EBITDA Growth Rate %43.7ROA % (ttm)18.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)24.7Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M236ROI % (ttm)19.7Gross Margin Increase y-yN

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBKen Fisher 2014-06-30 Add0.05%$274 - $320.13
($300.74)
$ 311.414%Add 386.61%88,885
BIIBRon Baron 2014-06-30 Add$274 - $320.13
($300.74)
$ 311.414%Add 41.76%8,632
BIIBKen Heebner 2014-06-30 Sold Out -0.95%$274 - $320.13
($300.74)
$ 311.414%Sold Out0
BIIBAndreas Halvorsen 2014-06-30 Sold Out -0.5%$274 - $320.13
($300.74)
$ 311.414%Sold Out0
BIIBJoel Greenblatt 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 311.414%Sold Out0
BIIBGeorge Soros 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 311.414%Sold Out0
BIIBJohn Burbank 2014-06-30 Sold Out -0.01%$274 - $320.13
($300.74)
$ 311.414%Sold Out0
BIIBKen Heebner 2014-03-31 Buy 0.95%$273.518 - $351.94
($316.4)
$ 311.41-2%New holding, 116000 sh.116,000
BIIBAndreas Halvorsen 2014-03-31 Buy 0.5%$273.518 - $351.94
($316.4)
$ 311.41-2%New holding, 388900 sh.388,900
BIIBGeorge Soros 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 311.41-2%New holding, 7500 sh.7,500
BIIBJoel Greenblatt 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 311.41-2%New holding, 3931 sh.3,931
BIIBRon Baron 2014-03-31 Buy 0.01%$273.518 - $351.94
($316.4)
$ 311.41-2%New holding, 6089 sh.6,089
BIIBJohn Burbank 2014-03-31 Buy 0.01%$273.518 - $351.94
($316.4)
$ 311.41-2%New holding, 783 sh.783
BIIBKen Fisher 2014-03-31 Add0.01%$273.518 - $351.94
($315.54)
$ 311.41-1%Add 796.27%18,266
BIIBVanguard Health Care Fund 2014-03-31 Reduce-0.24%$273.518 - $351.94
($315.54)
$ 311.41-1%Reduce -32.19%599,400
BIIBRay Dalio 2014-03-31 Sold Out -0.04%$273.518 - $351.94
($316.4)
$ 311.41-2%Sold Out0
BIIBRay Dalio 2013-12-31 Add0.03%$223.85 - $295.88
($258.53)
$ 311.4120%Add 208.67%19,057
BIIBJohn Hussman 2013-12-31 Sold Out -0.99%$223.85 - $295.88
($258.53)
$ 311.4120%Sold Out0
BIIBVanguard Health Care Fund 2013-12-31 Reduce-0.47%$223.85 - $295.88
($258.53)
$ 311.4120%Reduce -39.09%884,000
BIIBAndreas Halvorsen 2013-12-31 Sold Out -0.39%$223.85 - $295.88
($258.53)
$ 311.4120%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BIIB Ken Fisher 2014-06-3088,8850.040.06+386.61%
BIIB Ron Baron 2014-06-308,63200.01+41.76%
BIIB Mario Gabelli 2014-06-304,17500.01+16.46%
BIIB Frank Sands 2014-06-304,891,4632.073.9+0.38%
BIIB PRIMECAP Management 2014-06-3017,258,3117.316-1.39%
BIIB Vanguard Health Care Fund 2014-06-30559,7000.240.47-6.62%
BIIB George Soros 2014-06-30000Sold Out
BIIB Joel Greenblatt 2014-06-30000Sold Out
BIIB John Burbank 2014-06-30000Sold Out
BIIB Andreas Halvorsen 2014-06-30000Sold Out
BIIB Ken Heebner 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Holtzman Steven HEVP Corporate Development 2014-10-01Sell1,750$330.97-5.91view
SCANGOS GEORGE ACEO 2014-10-01Sell1,127$330.97-5.91view
SCANGOS GEORGE ACEO 2014-09-02Sell1,128$345.47-9.86view
SCANGOS GEORGE ACEO 2014-08-01Sell1,128$332.93-6.46view
SCANGOS GEORGE ACEO 2014-07-16Sell12,316$312.37-0.31view
Posner Brian SDirector 2014-06-20Sell605$315-1.14view
Posner Brian SDirector 2014-06-13Sell700$310.50.29view
SCANGOS GEORGE ACEO 2014-06-02Sell484$318.93-2.36view
Holtzman Steven HEVP Corporate Development 2014-05-19Sell1,221$289.157.7view
SCANGOS GEORGE ACEO 2014-05-01Sell2,123$285.569.05view

Press Releases about BIIB :

    Quarterly/Annual Reports about BIIB:

    News about BIIB:

    Articles On GuruFocus.com
    Ebola Diagnosis in U.S. Raises Pharmaceutical Stock by 20% Oct 01 2014 
    A Few Reasons Why AbbVie's Momentum Will Continue Sep 25 2014 
    Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 
    Ken Fisher's Top Increaes of the Second Quarter Jul 28 2014 
    Ken Fisher's Top Increases of the First Quarter Apr 22 2014 
    Weekly 52-Week Highs Highlight: ORLY, LLL, BIIB, NVS Feb 09 2014 
    Weekly CFO Sells Highlight: CSOD, UTX, MEMS, SBAC, BIIB Sep 22 2013 
    PRIMECAP Trims Top Biotechs and More Aug 30 2013 
    Edward Owens’ Vanguard Health Care Fund Does More Shedding than Adding in Third Quarter Nov 01 2012 
    52-Week High Guru Stocks: BIIB, GE, BDX, IR, PFE Sep 24 2012 


    More From Other Websites
    Will Biogen Idec (BIIB) Pull a Surprise this Earnings Season? Oct 20 2014
    Celgene's Crohn's Disease Drug Hits Its Marks Oct 20 2014
    Celgene, Alexion Among 4 IBD 50 Medicals To Report Oct 18 2014
    The Best-Selling Biologic Drugs Oct 16 2014
    Baxter Q3 Beats As Hemophilia Drugs Fend Off Rivals Oct 16 2014
    US STOCKS-Major indexes end down, but well off session lows Oct 15 2014
    US STOCKS-Major indexes end down, but well off session lows Oct 15 2014
    IPO Stock Watch: Biotech Forward Pharma Falls On IPO Oct 15 2014
    US STOCKS-Major indexes down more than 1 pct but off day's lows Oct 15 2014
    US STOCKS-Major indexes down more than 1 pct but off day's lows Oct 15 2014
    Biogen Idec and Gretchen Rubin Unveil MS BlueprintTM, a New Online Tool to Help People with Multiple... Oct 15 2014
    Biogen Idec and Gretchen Rubin Unveil MS BlueprintTM, a New Online Tool to Help People with Multiple... Oct 15 2014
    IPO Calendar: Biotech Companies Lead List Of 7 IPOs Oct 13 2014
    Which Fund Has The Most To Gain From Biogen Idec? Oct 13 2014
    Market bright spots Oct 10 2014
    Short Interest in Biotech Becomes Company Specific Oct 10 2014
    Biogen Idec Inc's Stock Is Set To Drop Oct 09 2014
    CORRECTING and REPLACING Biogen Idec To Report Third Quarter 2014 Financial Results on October 22,... Oct 08 2014
    Large-Cap Growth Under Repair Oct 07 2014
    Will Biotech Beat This Earnings Season? Oct 06 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK